Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.35
$0.25
$1.28
$17.03M1.19168,181 shs4.12 million shs
OpGen, Inc. stock logo
OPGN
OpGen
$4.70
-3.7%
$4.26
$0.53
$5.25
$47.32M-1.7110,352 shs6,618 shs
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$7.30
-4.1%
$8.64
$7.00
$33.73
$52.43M0.9420,437 shs6,679 shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$1.81
+3.1%
$2.07
$1.35
$4.07
$77.78M0.65354,251 shs760,733 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%0.00%-37.02%-69.34%
OpGen, Inc. stock logo
OPGN
OpGen
0.00%-4.08%-3.49%+282.11%+37.03%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
0.00%-8.64%-23.16%-29.88%-70.92%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.00%+28.01%-15.65%-28.94%-43.77%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/AN/AN/AN/AN/AN/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/AN/AN/AN/AN/AN/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
1.8866 of 5 stars
3.35.00.00.00.00.80.6
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
1.8477 of 5 stars
3.51.00.00.02.31.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
0.00
N/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
2.50
Moderate Buy$16.25122.60% Upside
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
3.00
Buy$2.8557.89% Upside

Current Analyst Ratings Breakdown

Latest ENZ, QIPT, PIII, and OPGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00 ➝ $4.00
5/13/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$4.00 ➝ $1.70
4/21/2025
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$50.00 ➝ $20.00
(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
OpGen, Inc. stock logo
OPGN
OpGen
$2.67M17.70N/AN/A($11.55) per share-0.41
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$1.49B0.04$3.15 per share2.32$0.45 per share16.22
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$240.85M0.32$0.71 per share2.56$2.47 per share0.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%6/12/2025 (Estimated)
OpGen, Inc. stock logo
OPGN
OpGen
-$32.67MN/A0.00N/A-1,140.36%N/A-287.58%6/2/2025 (Estimated)
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$57.77M-$47.28N/AN/AN/A-6.95%-71.31%-11.93%8/6/2025 (Estimated)
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.21N/AN/AN/A-2.90%-6.70%-2.94%8/13/2025 (Estimated)

Latest ENZ, QIPT, PIII, and OPGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$5.00-$6.28-$1.28-$6.28$362.09 million$373.23 million
5/12/2025Q2 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.02-$0.07-$0.09-$0.07$88.29 million$57.40 million
3/27/2025Q4 2024
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$8.50-$16.00-$7.50-$0.36$378.88 million$370.69 million
3/17/2025Q2 2025
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A-$0.02N/A-$0.03N/A$7.33 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/AN/AN/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
OpGen, Inc. stock logo
OPGN
OpGen
N/A
5.45
5.45
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
1.11
0.53
0.53
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.74
1.22
0.87

Institutional Ownership

CompanyInstitutional Ownership
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
OpGen, Inc. stock logo
OPGN
OpGen
2.68%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
7.75%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
42.85%

Insider Ownership

CompanyInsider Ownership
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
OpGen, Inc. stock logo
OPGN
OpGen
43.80%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
17.79%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
13.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
OpGen, Inc. stock logo
OPGN
OpGen
10010.07 million4.70 millionNot Optionable
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
5007.18 million294.74 millionNot Optionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
80043.09 million37.32 millionOptionable

Recent News About These Companies

Quipt Home Medical (QIPT) Gets a Buy from Stifel Nicolaus
What is Leede Financial's Estimate for QIPT FY2025 Earnings?
Quipt Home Medical (QIPT) Receives a Buy from Stifel Nicolaus

New MarketBeat Followers Over Time

Media Sentiment Over Time

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

OpGen stock logo

OpGen NASDAQ:OPGN

$4.70 -0.18 (-3.69%)
As of 05/23/2025 03:43 PM Eastern

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

P3 Health Partners stock logo

P3 Health Partners NASDAQ:PIII

$7.30 -0.31 (-4.07%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$7.28 -0.02 (-0.34%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$1.80 +0.06 (+3.14%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$1.84 +0.04 (+1.94%)
As of 05/23/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.